[#item_full_content] In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval. 
Read More
Judge Takes CMS HEMP-MARIJUANA CBD Program Under Advisement – As Evidence Mounts That Medicare May Be Moving Ahead of FDA Science
ByPot Shop News
May 8, 2026